These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15211476)

  • 1. Diagnostic utility of CDX-2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks.
    Saad RS; Essig DL; Silverman JF; Liu Y
    Cancer; 2004 Jun; 102(3):168-73. PubMed ID: 15211476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma.
    Levine PH; Joutovsky A; Cangiarella J; Yee H; Simsir A
    Diagn Cytopathol; 2006 Mar; 34(3):191-5. PubMed ID: 16470859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
    Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
    Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
    Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain.
    Strickland-Marmol LB; Khoor A; Livingston SK; Rojiani A
    Arch Pathol Lab Med; 2007 Nov; 131(11):1686-90. PubMed ID: 17979487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
    Franchi A; Massi D; Palomba A; Biancalani M; Santucci M
    Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
    Afify AM; al-Khafaji BM
    Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
    Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
    Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin.
    Li MK; Folpe AL
    Adv Anat Pathol; 2004 Mar; 11(2):101-5. PubMed ID: 15090846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
    Raspollini MR; Baroni G; Taddei A; Taddei GL
    Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.
    Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H
    Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
    Ng WK; Chow JC; Ng PK
    Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
    Aulakh KS; Chisholm CD; Smith DA; Speights VO
    Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids.
    Saqi A; Alexis D; Remotti F; Bhagat G
    Am J Clin Pathol; 2005 Mar; 123(3):394-404. PubMed ID: 15716236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
    Werling RW; Yaziji H; Bacchi CE; Gown AM
    Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.